ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,298, issued on Dec. 2, was assigned to WUXI BIOLOGICS IRELAND Ltd. (Dundalk, Ireland).
"Anti-CD3epsilon antibodies" was invented by Jing Li (Shanghai) and Qin Mei (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides isolated monoclonal anti-CD3epsilon antibodies or antigen-binding fragments thereof comprising one or more heavy chain CDR sequences selected from the group consisting of: SEQ ID NOs: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, and 47, and/or one or more kappa light chain CDR sequences selected from the group consisting of: SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 1...